Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth I Connor

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
The Journal of Infectious Diseases|July 5, 2020
A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in LithuaniaAnanda S Bandyopadhyay, Chris Gast, Elizabeth B Brickley, et al.
Frontiers in Immunology|February 15, 2021
Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent IndividualsSavannah E Butler, Andrew R Crowley, Harini Natarajan, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2023
Characteristics and functions of infection-enhancing antibodies to the N-terminal domain of SARS-CoV-2Ruth I Connor, Mrunal Sakharkar, C Garrett Rappazzo, et al.
Immunity|February 4, 2018
Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic HypermutationEileen Goodwin, Morgan S A Gilman, Daniel Wrapp, et al.
The Lancet. Infectious Diseases|September 18, 2016
Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infantsPeter F Wright, Ruth I Connor, Wendy F Wieland-Alter, et al.
Nature Communications|April 19, 2023
Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineagesMark Chernyshev, Mrunal Sakharkar, Ruth I Connor, et al.
Plos One|May 13, 2017
Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901C Fordham von Reyn, Timothy Lahey, Robert D Arbeit, et al.
Open Forum Infectious Diseases|July 16, 2016
Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza VaccinePeter F Wright, Anne G Hoen, Natalia A Ilyushina, et al.
AIDS (London, England)|February 1, 2019
Sialic acid levels in breast milk from HIV-positive Tanzanian women and impact of maternal dietRuth I Connor, Muhammad Zain-Ul-Abideen, Albert K Magohe, et al.
Science Immunology|February 24, 2021
Prolonged evolution of the human B cell response to SARS-CoV-2 infectionMrunal Sakharkar, C Garrett Rappazzo, Wendy F Wieland-Alter, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|July 5, 2020
A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in LithuaniaAnanda S Bandyopadhyay, Chris Gast, Elizabeth B Brickley, et al.
Frontiers in Immunology|February 15, 2021
Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent IndividualsSavannah E Butler, Andrew R Crowley, Harini Natarajan, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2023
Characteristics and functions of infection-enhancing antibodies to the N-terminal domain of SARS-CoV-2Ruth I Connor, Mrunal Sakharkar, C Garrett Rappazzo, et al.
Immunity|February 4, 2018
Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic HypermutationEileen Goodwin, Morgan S A Gilman, Daniel Wrapp, et al.
The Lancet. Infectious Diseases|September 18, 2016
Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infantsPeter F Wright, Ruth I Connor, Wendy F Wieland-Alter, et al.
Nature Communications|April 19, 2023
Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineagesMark Chernyshev, Mrunal Sakharkar, Ruth I Connor, et al.
Plos One|May 13, 2017
Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901C Fordham von Reyn, Timothy Lahey, Robert D Arbeit, et al.
Open Forum Infectious Diseases|July 16, 2016
Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza VaccinePeter F Wright, Anne G Hoen, Natalia A Ilyushina, et al.
AIDS (London, England)|February 1, 2019
Sialic acid levels in breast milk from HIV-positive Tanzanian women and impact of maternal dietRuth I Connor, Muhammad Zain-Ul-Abideen, Albert K Magohe, et al.
Science Immunology|February 24, 2021
Prolonged evolution of the human B cell response to SARS-CoV-2 infectionMrunal Sakharkar, C Garrett Rappazzo, Wendy F Wieland-Alter, et al.
Pageof 5